SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Brock International (NASDAQ: BROC, the forgotten stock)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bob Trocchi who wrote (714)10/16/1997 9:26:00 AM
From: hasbeen101   of 928
 
Yes, I think niche marketing to pharmaceutical sales reps is a great idea. There is lots of money in drugs (even the legal kind!) I have known a couple of pharmaceutical reps and the drug companies are not scared of spending on marketing tools.

The impressive thing about Siebel is that they are a very marketing-focused company. This is a double plus when your target market is ... marketers. They of all people should appreciate good marketing.

BTW I am long BROC and think it is a better investment than Siebel at current valuations. But BROC can learn a few lessons from Siebel.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext